203 related articles for article (PubMed ID: 28232942)
21. Prescribing pattern of psychotropic drugs in nursing home residents with dementia.
Wetzels RB; Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
Int Psychogeriatr; 2011 Oct; 23(8):1249-59. PubMed ID: 21682938
[TBL] [Abstract][Full Text] [Related]
22. Differences in prescribing psychotropic drugs for elderly with depression.
Huang YC; Wang LJ; Chong MY
Acta Neuropsychiatr; 2016 Oct; 28(5):296-303. PubMed ID: 26899461
[TBL] [Abstract][Full Text] [Related]
23. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts.
Ruths S; Sørensen PH; Kirkevold Ø; Husebø BS; Krüger K; Halvorsen KH; Selbaek G
Int J Geriatr Psychiatry; 2013 Aug; 28(8):868-76. PubMed ID: 23147389
[TBL] [Abstract][Full Text] [Related]
24. Geographic variation in psychotropic drug utilisation among older people in New Zealand.
Ndukwe HC; Wang T; Tordoff JM; Croucher MJ; Nishtala PS
Australas J Ageing; 2016 Dec; 35(4):242-248. PubMed ID: 26991493
[TBL] [Abstract][Full Text] [Related]
25. Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases.
Liu X; Ye W; Watson P; Tepper P
J Nerv Ment Dis; 2010 Aug; 198(8):544-50. PubMed ID: 20699718
[TBL] [Abstract][Full Text] [Related]
26. Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.
Pharoah PD; Melzer D
Br J Gen Pract; 1995 Nov; 45(400):595-9. PubMed ID: 8554839
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence of psychoactive drug consumption in an obese population].
Cerdá Esteve MA; Barral Tafalla D; Gudelis M; Goday A; Farre Albaladejo M; Cano JF
Endocrinol Nutr; 2010 Apr; 57(4):155-9. PubMed ID: 20223715
[TBL] [Abstract][Full Text] [Related]
28. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.
Huerta C; Abbing-Karahagopian V; Requena G; Oliva B; Alvarez Y; Gardarsdottir H; Miret M; Schneider C; Gil M; Souverein PC; De Bruin ML; Slattery J; De Groot MC; Hesse U; Rottenkolber M; Schmiedl S; Montero D; Bate A; Ruigomez A; García-Rodríguez LA; Johansson S; de Vries F; Schlienger RG; Reynolds RF; Klungel OH; de Abajo FJ
Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():56-65. PubMed ID: 26149383
[TBL] [Abstract][Full Text] [Related]
29. Natural history of pharmacotherapy of older depressed community residents. The MRC-ALPHA Study.
Wilson KC; Copeland JR; Taylor S; Donoghue J; McCracken CF
Br J Psychiatry; 1999 Nov; 175():439-43. PubMed ID: 10789275
[TBL] [Abstract][Full Text] [Related]
30. [Effect of the economic crisis on consumption of psychotropic drugs in Asturias (Spain)].
Nicieza-García ML; Alonso-Lorenzo JC; Suárez-Gil P; Rilla-Villar N
Gac Sanit; 2016; 30(6):464-467. PubMed ID: 27017197
[TBL] [Abstract][Full Text] [Related]
31. The effects of becoming a physician on prescription drug use and mental health treatment.
Mark Anderson D; Diris R; Montizaan R; Rees DI
J Health Econ; 2023 Sep; 91():102774. PubMed ID: 37451143
[TBL] [Abstract][Full Text] [Related]
32. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.
Lesén E; Carlsten A; Skoog I; Waern M; Petzold M; Börjesson-Hanson A
Int Psychogeriatr; 2011 Oct; 23(8):1270-7. PubMed ID: 21447258
[TBL] [Abstract][Full Text] [Related]
33. Concomitant prescribing of tranquilizers and hypnotics among patients receiving antidepressant prescriptions.
Bingefors K; Isacson DG
Ann Pharmacother; 1998 May; 32(5):531-5. PubMed ID: 9606472
[TBL] [Abstract][Full Text] [Related]
34. [Determining factors for the use of anxiolytic and hypnotic drugs in the elderly].
Téllez-Lapeira JM; López-Torres Hidalgo J; Gálvez-Alcaraz L; Párraga-Martínez I; Boix-Gras C; García-Ruiz A
Rev Esp Geriatr Gerontol; 2017; 52(1):31-34. PubMed ID: 26923262
[TBL] [Abstract][Full Text] [Related]
35. The impact of the Canterbury earthquakes on dispensing for older person's mental health.
Beaglehole B; Bloomer C; Zhang T; Hamilton G; Boden JM; Mulder RT; Bell C; Frampton C
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1599-1604. PubMed ID: 31291027
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory Actions of Antidepressants, Hypnotics, and Anxiolytics on Recombinant Human Acetylcholinesterase Activity.
Obara K; Mori H; Ihara S; Yoshioka K; Tanaka Y
Biol Pharm Bull; 2024; 47(1):328-333. PubMed ID: 38296462
[TBL] [Abstract][Full Text] [Related]
37. Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
PLoS One; 2018; 13(6):e0199218. PubMed ID: 29920564
[TBL] [Abstract][Full Text] [Related]
38. Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.
Tsimtsiou Z; Ashworth M; Jones R
Br J Gen Pract; 2009 Jun; 59(563):e191-8. PubMed ID: 19520017
[TBL] [Abstract][Full Text] [Related]
39. Prescribing changes in anxiolytics and antidepressants in Slovenia.
Svab V; Subelj M; Vidmar G
Psychiatr Danub; 2011 Jun; 23(2):178-82. PubMed ID: 21685857
[TBL] [Abstract][Full Text] [Related]
40. Relationship between antidepressant and anxiolytic/hypnotic prescribing: a mixed-methods study.
Morrison J; Anderson MJ; Mac Donald S; Maxwell M; Munoz-Arroyo R; Power A; Smith M; Sutton M; Wilson P
Eur J Gen Pract; 2008; 14(3-4):129-35. PubMed ID: 19107642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
